Children with childhood apraxia of speech (CAS) tend to require intensive treatment programs to make improvements. The Nuffield Dyspraxia Program has been shown to be an effective treatment approach for these children. However, prior research consisted of 1-hour treatment sessions, which are not always feasible for children, families, or speech therapists. Therefore, this study sought to determine the effectiveness of the NDP3 when used in short, frequent sessions.
